Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Science to Business Program

University of Alberta

$50,000.00

Applications of Lactic Acid Bacteria in Infection Prevention and Treatment

EF 2011-12

Résumé
Bacteria are becoming resistant to a vast array of different antibiotics and the discovery of new drugs for combating infections is lagging behind. Therefore, alternative prevention and treatment options are urgently needed to address this serious issue. The primary aim of my doctoral research is to use so called "friendly" Lactic Acid Bacteria (LAB), and some of the compounds that they produce to aid the development of new probiotic applications that can promote health through studies in farm animals and respective models. One part of my research was focused on the use of potentially beneficial LAB in treating uterine infections in dairy cows. My research results showed that the selected LAB were able to lower the occurrence and the severity of the disease, indirectly increase milk production and prevent dairy cows from being culled. With promising results obtained, I began conducting a different study on using LAB produced sugar polymers or glycans for preventing gastrointestinal infections. Since certain components of the cell surface of intestinal cells that harmful bacteria bind to cause infection are identical to those found on the surface of red blood cells, I chose to use red blood cells from pigs as my test system. I found that only glycans isolated from a bacterium called Lactobacillus reuteri but not currently available commercial glycans were able to prevent the binding. Wanting to generate more different types of glycans and prevent a wider range of harmful bacteria from causing infection, I subsequently cloned an enzyme which produced more specific types of glycans. Overall, I believe my studies are tremendously relevant to the area of biomedicine as they will help with the development of new therapeutic applications as functional foods and nutraceuticals for preventing and treating urogenital and gastrointestinal infections in farm animals and people alike.
Programme
Science to Business Program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
256951
Name
Wang Yvonne
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Science to Business
Projecttitle
Applications of Lactic Acid Bacteria in Infection Prevention and Treatment
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
Science to Business Program
Keyworddelim
Alpha-Galactooligosaccharides; Antimicrobial Peptides; Cloning; Dna Sequencing; Exopolysaccharides; Haemagglutination Assays; High Pressure Liquid Chromatography; Lactic Acid Bacteria; Microbiota Characterization; Probiotics
Abstract
Bacteria are becoming resistant to a vast array of different antibiotics and the discovery of new drugs for combating infections is lagging behind. Therefore, alternative prevention and treatment options are urgently needed to address this serious issue. The primary aim of my doctoral research is to use so called "friendly" Lactic Acid Bacteria (LAB), and some of the compounds that they produce to aid the development of new probiotic applications that can promote health through studies in farm animals and respective models. One part of my research was focused on the use of potentially beneficial LAB in treating uterine infections in dairy cows. My research results showed that the selected LAB were able to lower the occurrence and the severity of the disease, indirectly increase milk production and prevent dairy cows from being culled. With promising results obtained, I began conducting a different study on using LAB produced sugar polymers or glycans for preventing gastrointestinal infections. Since certain components of the cell surface of intestinal cells that harmful bacteria bind to cause infection are identical to those found on the surface of red blood cells, I chose to use red blood cells from pigs as my test system. I found that only glycans isolated from a bacterium called Lactobacillus reuteri but not currently available commercial glycans were able to prevent the binding. Wanting to generate more different types of glycans and prevent a wider range of harmful bacteria from causing infection, I subsequently cloned an enzyme which produced more specific types of glycans. Overall, I believe my studies are tremendously relevant to the area of biomedicine as they will help with the development of new therapeutic applications as functional foods and nutraceuticals for preventing and treating urogenital and gastrointestinal infections in farm animals and people alike.
Competitiondate
201202
Approvedterm2
1 yr 8 mths
Pinamesdelim
Wang, Yvonne
Approvedterm
1 an 8 mois
Cihrcontribution2
Knowledge Translation Branch~ $50,000~ $0~